Navigation Links
CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
Date:10/14/2008

ORLANDO, Fla., Oct. 14 /PRNewswire/ -- Dr. Eliane Gluckman, recognized as a pioneer and leader in the field of cord blood stem cell transplantation, has joined the team at CORD:USE Cord Blood Bank. "We are honored to have such an accomplished physician as Dr. Gluckman join our team of highly esteemed physicians and scientists at CORD:USE," says Edward Guindi M.D., President and CEO of CORD:USE.

Dr. Gluckman is internationally recognized as the pioneering physician who performed the world's first successful cord blood transplant (sibling donor) in 1988. In fact, leaders from the international cord blood community will be meeting in Mandelieu, France, for a cord blood conference this week, on October 16-19, to celebrate the 20th anniversary of that first cord blood transplantation by Dr. Gluckman. CORD:USE team members, Dr. Broxmeyer and Dr. Kurtzberg, also played significant roles in this historic transplant. The conference will also focus on the Biology and Clinical Applications of Cord Blood Cells.

Dr. Gluckman is Professor of Hematology at the University of Paris VII. She is the head of the International Registry on Cord Blood Transplantation, Eurocord, at the Hospital Saint Louis APHP and President of the European School of Hematology. Dr. Gluckman is a founding member and former President of the European Group of Bone Marrow Transplantation (EBMT). During her 30 years as a transplanter, Dr. Gluckman has performed over 1,900 bone marrow and cord blood transplants.

"I am very honored to join the team at CORD:USE. I am particularly glad to participate with long time friends at CORD:USE who have initiated and developed the technology and the clinical use of cord blood transplants," says Dr. Gluckman. "The experience and expertise of the team at CORD:USE will certainly increase the development of cord blood banking, its clinical use and new research on stem cells for regenerative medicine."

Dr. Gluckman joins other highly-respected pioneers and leaders in the field of cord blood stem cell transplantation on the CORD:USE team:

-- Dr. Joanne Kurtzberg, Director of the Pediatric Blood and Marrow Program at Duke University and Medical Director of the CORD:USE Cord Blood Bank at Duke. She performed the first successful cord blood transplant from an unrelated donor in 1993 and has since performed 900 umbilical cord blood transplants.

-- Dr. Hal Broxmeyer, the current Vice President and President Elect of the American Society of Hematology. Broxmeyer is a founder of the field of cord blood stem cell transplantation and widely recognized as one of the foremost experts in the world in cord blood stem cell science.

-- Dr. John Wagner, an expert in unrelated hematopoietic stem cell transplantation. Dr. Wagner's study of the use of two cord blood units for transplantation has made it possible for many more adults to benefit from cord blood stem cell transplantation who would have otherwise not been candidates for this therapy.

-- Dr. Alan Levine serves as the company's Chief Scientific Officer. Dr. Levine enjoyed a highly successful 25 year career with the National Institutes of Health ("NIH") where he was most recently the Director of the Blood Disease Program of the National Heart, Lung, and Blood Institute of the NIH. In this capacity, Dr. Levine was responsible for initiating the bone marrow and umbilical cord blood research programs at the NIH.

-- Dr. Esmail Zanjani, a world-renowned expert in blood stem cell biology, has led the development of the field of in utero stem cell transplantation and gene therapy as a means of curing genetic diseases prior to birth.

About CORD:USE Cord Blood Bank, Inc.

CORD:USE Cord Blood Bank, headquartered in Orlando, Florida is creating a large, ethnically diverse, high quality inventory of available cord blood stem cell units for the many patients in need of a potentially life-saving transplant. CORD:USE Cord Blood Bank has entered into agreements with hospitals across the country to provide mothers the option to donate their babies' cord blood. CORD:USE makes these cord blood units available to transplanters, throughout the country and around the world, as a critical component in their patients' treatment. CORD:USE lists all of its units on the National Marrow Donor Program's Registry. For more information, please visit our website, http://www.corduse.com .


'/>"/>
SOURCE CORD:USE Cord Blood Bank, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. CORD:USE Cord Blood Bank Announces the Addition of Dr. John Wagner, a Pioneer in the Use of Umbilical Cord Blood Stem Cells, to Its Scientific Advisory Board
2. Two-time Defending NASCAR Sprint Cup Series Champion Jimmie Johnson Joins the Team at CORD:USE Cord Blood Bank to Help Win the Race for Life
3. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
4. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
5. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
6. The International Diabetes Federation (IDF) Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes
7. CDC Awards NATT Funding to Improve Blood Clot Awareness
8. FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
9. Cellestis Receives FDA Approval for Blood Test for Detecting Tuberculosis
10. Blood Donations in U.S. Testing Positive for Chagas Disease
11. One of Nations Oldest Blood Services Providers Turns to Sysmex America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):